Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories medical Devices — Segment Operating Earnings ($M) ($M)
Postgres DB segment_values + Form 10-K/10-Q XBRL
Latest, Q2 2026
1,969
Period ended Jun 30, 2026
Change on a year earlier
+9.6%
1,796 in Q2 2025
History
30 quarters
Since Q1 2019
Sources
21
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Medical Devices — Segment Operating Earnings ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 1,969 | +9.6% | Form 10-Q (filed 2026-07-28) ↗ |
| Q1 2026 | Mar 31, 2026 | 1,893 | +17.7% | Form 10-Q (filed 2026-04-29) ↗ |
| Q4 2025 | Dec 31, 2025 | 1,978 | +11.6% | Form 10-K (filed 2026-02-20) ↗ |
| Q3 2025 | Sep 30, 2025 | 1,829 | +20.9% | Form 10-Q (filed 2025-10-29) ↗ |
| Q2 2025 | Jun 30, 2025 | 1,796 | +19.2% | Form 10-Q (filed 2025-07-30) ↗ |
| Q1 2025 | Mar 31, 2025 | 1,609 | +18.3% | Form 10-Q (filed 2025-04-30) ↗ |
| Q4 2024 | Dec 31, 2024 | 1,773 | +18.1% | Form 10-K (filed 2025-02-21) ↗ |
| Q3 2024 | Sep 30, 2024 | 1,513 | +12.7% | Form 10-Q (filed 2024-10-31) ↗ |
| Q2 2024 | Jun 30, 2024 | 1,507 | +8.8% | Form 10-Q (filed 2024-07-31) ↗ |
| Q1 2024 | Mar 31, 2024 | 1,360 | +26.2% | Form 10-Q (filed 2024-05-02) ↗ |
| Q4 2023 | Dec 31, 2023 | 1,501 | +30.7% | Form 10-K (filed 2024-02-16) ↗ |
| Q3 2023 | Sep 30, 2023 | 1,342 | +28.4% | Form 10-Q (filed 2023-11-01) ↗ |
| Q2 2023 | Jun 30, 2023 | 1,385 | +19.4% | Form 10-Q (filed 2023-08-03) ↗ |
| Q1 2023 | Mar 31, 2023 | 1,078 | -0.5% | Form 10-Q (filed 2023-05-04) ↗ |
| Q4 2022 | Dec 31, 2022 | 1,148 | -0.9% | Form 10-K (filed 2024-02-16) ↗ |
| Q3 2022 | Sep 30, 2022 | 1,045 | -9.9% | Form 10-Q (filed 2023-11-01) ↗ |
| Q2 2022 | Jun 30, 2022 | 1,160 | -4.0% | Form 10-Q (filed 2023-08-03) ↗ |
| Q1 2022 | Mar 31, 2022 | 1,083 | +7.5% | Form 10-Q (filed 2023-05-04) ↗ |
| Q4 2021 | Dec 31, 2021 | 1,158 | +26.4% | Form 10-K (filed 2024-02-16) ↗ |
| Q3 2021 | Sep 30, 2021 | 1,160 | +25.0% | Form 10-Q (filed 2021-11-03) ↗ |
| Q2 2021 | Jun 30, 2021 | 1,208 | +209.0% | Form 10-Q (filed 2021-08-04) ↗ |
| Q1 2021 | Mar 31, 2021 | 1,007 | +25.4% | Form 10-Q (filed 2021-05-05) ↗ |
| Q4 2020 | Dec 31, 2020 | 916 | -12.5% | Form 10-K (filed 2021-02-19) ↗ |
| Q3 2020 | Sep 30, 2020 | 928 | -3.1% | Form 10-Q (filed 2020-11-04) ↗ |
| Q2 2020 | Jun 30, 2020 | 391 | -57.4% | Form 10-Q (filed 2020-07-29) ↗ |
| Q1 2020 | Mar 31, 2020 | 803 | -5.2% | Form 10-Q (filed 2020-04-29) ↗ |
| Q4 2019 | Dec 31, 2019 | 1,047 | – | Form 10-Q (filed 2020-11-04) ↗ |
| Q3 2019 | Sep 30, 2019 | 958 | – | Form 10-Q (filed 2020-11-04) ↗ |
| Q2 2019 | Jun 30, 2019 | 917 | – | Form 10-Q (filed 2020-07-29) ↗ |
| Q1 2019 | Mar 31, 2019 | 847 | – | Form 10-Q (filed 2020-04-29) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Medical Devices — Segment Operating Earnings ($M) ($M), quarterly Q1 2019–Q2 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-seg-opinc-md
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.